001360.KS · 삼성제약
South Korea · RS rating 44 · As of 2026-10-14
| Price | 1,320.00 KRW |
|---|---|
| 1-day change | +0.5% |
| RS rating (overall / 1M / 3M / 12M) | 44 / 55 / 52 / 42 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 22 / 19 / 33 |
| Industry group (rank) | Medical-Generic Drugs (76) |
| EPS growth Q/Q | -816.7% |
| Sales growth Q/Q | +9.8% |
| Distance from 52-week high | +40.3% |
| Market cap (USD) | $96.5M |